These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30690720)

  • 1. A two-stage experimental design for dilution assays.
    Ferguson JM; Miura TA; Miller CR
    Biometrics; 2019 Sep; 75(3):1009-1016. PubMed ID: 30690720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and analysis of serial limiting dilution assays with small sample sizes.
    Macken C
    J Immunol Methods; 1999 Jan; 222(1-2):13-29. PubMed ID: 10022369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and estimation in the limiting dilution assay when concentrations vary widely among samples.
    Parrish RS; Hazlett LJ
    J Biopharm Stat; 2000 May; 10(2):197-215. PubMed ID: 10803725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erratum: High-Throughput Identification of Resistance to Pseudomonas syringae pv. Tomato in Tomato using Seedling Flood Assay.
    J Vis Exp; 2023 Oct; (200):. PubMed ID: 37851522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bias-corrected confidence intervals for the concentration parameter in a dilution assay.
    Wang J; Basu S
    Biometrics; 1999 Mar; 55(1):111-6. PubMed ID: 11318144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fitting limiting dilution experiments with generalized linear models results in a test of the single-hit Poisson assumption.
    Bonnefoix T; Bonnefoix P; Verdiel P; Sotto JJ
    J Immunol Methods; 1996 Aug; 194(2):113-9. PubMed ID: 8765164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pragmatic approach to the design of population pharmacokinetic studies.
    Roy A; Ette EI
    AAPS J; 2005 Oct; 7(2):E408-20. PubMed ID: 16353920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of Fisher information matrix approximation methods in population optimal design calculations.
    Strömberg EA; Nyberg J; Hooker AC
    J Pharmacokinet Pharmacodyn; 2016 Dec; 43(6):609-619. PubMed ID: 27804003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of limiting dilution analysis experiments for helper T lymphocyte precursor frequency determination in the context of allogeneic bone marrow transplantation.
    Russell CA; Brøndsted L; Vindeløv LL
    J Immunol Methods; 1999 May; 225(1-2):113-24. PubMed ID: 10365788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing deviation for a set of serial dilution most probable numbers from a Poisson-binomial model.
    Blodgett RJ
    J AOAC Int; 2006; 89(1):166-71. PubMed ID: 16512243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graphical representation of a generalized linear model-based statistical test estimating the fit of the single-hit Poisson model to limiting dilution assays.
    Bonnefoix T; Bonnefoix P; Callanan M; Verdiel P; Sotto JJ
    J Immunol; 2001 Nov; 167(10):5725-30. PubMed ID: 11698445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Split-plot designs for robotic serial dilution assays.
    Buzas JS; Wager CG; Lansky DM
    Biometrics; 2011 Dec; 67(4):1189-96. PubMed ID: 21627628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The standard chi 2 test used in limiting dilution assays is insufficient for estimating the goodness-of-fit to the single-hit Poisson model.
    Bonnefoix T; Sotto JJ
    J Immunol Methods; 1994 Jan; 167(1-2):21-33. PubMed ID: 8308277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simulation-based validation of spatial capture-recapture models: A case study using mountain lions.
    Paterson JT; Proffitt K; Jimenez B; Rotella J; Garrott R
    PLoS One; 2019; 14(4):e0215458. PubMed ID: 31002709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of two experimental design approaches in applying conjoint analysis in patient-centered outcomes research: a randomized trial.
    Kinter ET; Prior TJ; Carswell CI; Bridges JF
    Patient; 2012; 5(4):279-94. PubMed ID: 23145548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the use of in-silico simulations to support experimental design: A case study in microbial inactivation of foods.
    Garre A; Peñalver-Soto JL; Esnoz A; Iguaz A; Fernandez PS; Egea JA
    PLoS One; 2019; 14(8):e0220683. PubMed ID: 31454353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population Fisher information matrix and optimal design of discrete data responses in population pharmacodynamic experiments.
    Ogungbenro K; Aarons L
    J Pharmacokinet Pharmacodyn; 2011 Aug; 38(4):449-69. PubMed ID: 21660504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The design of in vivo multifraction experiments to estimate the alpha-beta ratio.
    Taylor JM
    Radiat Res; 1990 Jan; 121(1):91-7. PubMed ID: 2300673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of spiking experiments to estimate the detection proportion of qualitative microbiological methods.
    Manju MA; Van Den Heuvel ER; IJzerman-Boon PC
    J Biopharm Stat; 2019; 29(1):30-55. PubMed ID: 29553884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the physical and stochastic representation of an indicator dilution curve as a gamma variate.
    Mischi M; den Boer JA; Korsten HH
    Physiol Meas; 2008 Mar; 29(3):281-94. PubMed ID: 18367805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.